Musetti SN, Huang L. Tinagl1 gene therapy suppresses growth and remodels the microenvironment of triple negative breast cancer. Mol Pharm. 2021 May 3;18(5):2032-8. doi: 10.1021/acs.molpharmaceut.1c00008
Raspa M, Sacco P, Candrilli SD, Bishop E, Petrillo J. Validity of a condition specific outcome measure for fragile X syndrome: the Aberrant Behaviour Checklist-utility index. J Intellect Disabil Res. 2016 Sep;60(9):844-55. doi: 10.1111/jir.12264
Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.